This article has been updated with additonal information from Courtagen Life Sciences and Medicinal Genomics.

NEW YORK (GenomeWeb) – Courtagen Life Sciences said today that it has closed its diagnostic neurology testing business. According to the firm's website, it no longer accepts patient samples. 

The company's wholly owned subsidiary, Medicinal Genomics Corporation (MGC), which provides cannabis genetics research and testing, will remain intact and Courtagen is taking on this name.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.